IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer

scientific article published on 8 August 2012

IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.4161/CC.21387
P932PMC publication ID3442896
P698PubMed publication ID22871729
P5875ResearchGate publication ID230632275

P50authorLaura FormentiniQ42325549
P2093author name stringJosé M Cuezva
María Sánchez-Aragó
Javier García-Bermúdez
P2860cites workThe structure of bovine F1-ATPase in complex with its regulatory protein IF1Q27641847
How the regulatory protein, IF1, inhibits F1-ATPase from bovine mitochondriaQ27648517
Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondriaQ28593536
The ATP synthase--a splendid molecular machineQ29617444
Transcriptional paradigms in mammalian mitochondrial biogenesis and functionQ29619590
Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancerQ30155975
The tumor suppressor function of mitochondria: translation into the clinics.Q37472327
The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative responseQ39395452
Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.Q39694624
Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viabilityQ42182860
P433issue16
P1104number of pages2
P304page(s)2963-2964
P577publication date2012-08-08
P1433published inCell CycleQ1254166
P1476titleIF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer
P478volume11

Reverse relations

cites work (P2860)
Q36958409ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer
Q35620290Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases
Q30837218Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer
Q36809594Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
Q38358175Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death.
Q28081608Metabolic control of cancer cell stemness: Lessons from iPS cells
Q89474868Overexpression of native IF1 downregulates glucose-stimulated insulin secretion by pancreatic INS-1E cells
Q38973743Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Q55172169Reduction of the ATPase inhibitory factor 1 (IF1) leads to visual impairment in vertebrates.
Q41831013The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells
Q38071479The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.

Search more.